Environmental Monitoring of Parvovirus B19 in the Kidney Transplantation Ward of a Chinese Teaching Hospital

References

• Cotmore SF, Agbandje-McKenna M, Canuti M, et al. ICTV virus taxonomy profile: parvoviridae. J Gen Virol. 2019;100(3):367–368. doi:10.1099/jgv.0.001212
   PubMed Web of Science ®Google Scholar
• Cnc Garcia R, Leon LA. Human parvovirus B19: a review of clinical and epidemiological aspects in Brazil. Future Microbiol. 2021;16(1):37–50. doi:10.2217/fmb-2020-0123
   Web of Science ®Google Scholar
• Mage V, Lipsker D, Barbarot S, et al. Different patterns of skin manifestations associated with parvovirus B19 primary infection in adults. J Am Acad Dermatol. 2014;71(1):62–69. doi:10.1016/j.jaad.2014.02.044
   Web of Science ®Google Scholar
• Qiu J, Söderlund-Venermo M, Young NS. Human parvoviruses. Clin Microbiol Rev. 2017;30(1):43–113. doi:10.1128/CMR.00040-16
   PubMed Web of Science ®Google Scholar
• Gallinella G. The clinical use of parvovirus B19 assays: recent advances. Expert Rev Mol Diagn. 2018;18(9):821–832. doi:10.1080/14737159.2018.1503537
   PubMed Web of Science ®Google Scholar
• de Jong EP, Walther FJ, Kroes AC, Oepkes D. Parvovirus B19 infection in pregnancy: new insights and management. Prenat Diagn. 2011;31(5):419–425. doi:10.1002/pd.2714
   Web of Science ®Google Scholar
• Bentata Y. Parvovirus B19 in kidney transplantation: key points and essential pitfalls to know. Infect Dis. 2021;53(6):404–408. doi:10.1080/23744235.2021.1893379
   PubMed Web of Science ®Google Scholar
• Zolnourian ZR, Curran MD, Rima BK, Coyle PV, O’Neill HJ, Middleton D. Parvovirus B19 in kidney transplant patients. Transplantation. 2000;69(10):2198–2202. doi:10.1097/00007890-200005270-00043
   Web of Science ®Google Scholar
• Eid AJ, Chen SF; AST Infectious Diseases Community of Practice. Human parvovirus B19 in solid organ transplantation. Am J Transplant. 2013;13(Suppl 4):201–205. doi:10.1111/ajt.12111
   PubMed Web of Science ®Google Scholar
• Mouthon L, Guillevin L, Tellier Z. Intravenous immunoglobulins in autoimmune- or parvovirus B19-mediated pure red-cell aplasia. Autoimmun Rev. 2005;4(5):264–269. doi:10.1016/j.autrev.2004.10.004
   Web of Science ®Google Scholar
• Bonvicini F, Mirasoli M, Gallinella G, Zerbini M, Musiani M, Roda A. PNA-based probe for quantitative chemiluminescent in situ hybridisation imaging of cellular parvovirus B19 replication kinetics. Analyst. 2007;132(6):519–523. doi:10.1039/b701664f
   Web of Science ®Google Scholar
• Lara-Medrano R, Martínez-Reséndez MF, Garza-González E, Medina-Torres AG, Camacho-Ortiz A. Outbreak of parvovirus B19 infection among anesthesiology and surgical fellows. Am J Infect Control. 2016;44(9):1069–1070. doi:10.1016/j.ajic.2015.12.004
   Web of Science ®Google Scholar
• Miyamoto K, Ogami M, Takahashi Y, et al. Outbreak of human parvovirus B19 in hospital workers. J Hosp Infect. 2000;45(3):238–241. doi:10.1053/jhin.2000.0771
   Web of Science ®Google Scholar
• Siegel JD, Rhinehart E, Jackson M, et al.; for the Healthcare Infection Control Practices Advisory Committee. 2007 guideline for isolation precautions: preventing transmission of infectious agents in healthcare settings. Available from: https://www.cdc.gov/infectioncontrol/guidelines/isolation/index.html. Accessed March 29, 2022.
   Google Scholar
• Neild G, Anderson M, Hawes S, Colvin BT. Parvovirus infection after renal transplant. Lancet. 1986;2(8517):1226–1227. doi:10.1016/S0140-6736(86)92245-2
   Web of Science ®Google Scholar
• Azzi A, Zakrzewska K, Bertoni E, Guidi S, Salvadori M. Persistent parvovirus B19 infections with different clinical outcomes in renal transplant recipients: diagnostic relevance of polymerase chain reaction (PCR) and of quantification of B19 DNA in sera. Clin Microbiol Infect. 1996;2(2):105–108. doi:10.1111/j.1469-0691.1996.tb00214.x
   Google Scholar
• Egbuna O, Zand MS, Arbini A, Menegus M, Taylor J. A cluster of parvovirus B19 infections in renal transplant recipients: a prospective case series and review of the literature. Am J Transplant. 2006;6(1):225–231. doi:10.1111/j.1600-6143.2005.01139.x
   Web of Science ®Google Scholar
• Moore G, Rickard H, Stevenson D, et al. Detection of SARS-CoV-2 within the healthcare environment: a multi-centre study conducted during the first wave of the COVID-19 outbreak in England. J Hosp Infect. 2021;108:189–196. doi:10.1016/j.jhin.2020.11.024
   PubMed Web of Science ®Google Scholar
• Chamseddine A, Soudani N, Kanafani Z, et al. Detection of influenza virus in air samples of patient rooms. J Hosp Infect. 2021;108:33–42. doi:10.1016/j.jhin.2020.10.020
   Web of Science ®Google Scholar
• Yu Y, Bao R, Lyu J, Wu J, Chen J, Peng W. Foscarnet therapy for pure red cell aplasia related to human parvovirus B19 infection in kidney transplant recipients: a preliminary exploration. Infect Drug Resist. 2021;14:2911–2923. doi:10.2147/IDR.S321936
   Web of Science ®Google Scholar
• Koppelman MH, Cuypers HT, Emrich T, Zaaijer HL. Quantitative real-time detection of parvovirus B19 DNA in plasma. Transfusion. 2004;44(1):97–103. doi:10.1046/j.0041-1132.2004.00610.x
   PubMed Web of Science ®Google Scholar
• Eid AJ, Brown RA, Patel R, Razonable RR. Parvovirus B19 infection after transplantation: a review of 98 cases. Clin Infect Dis. 2006;43(1):40–48. doi:10.1086/504812
   PubMed Web of Science ®Google Scholar
• Yu Y, Wei C, Lyu J, et al. Donor-derived human parvovirus B19 infection in kidney transplantation. Front Cell Infect Microbiol. 2021;11:753970. doi:10.3389/fcimb.2021.753970
   Web of Science ®Google Scholar
• Cavalli A, Marinaro M, Desario C, Corrente M, Camero M, Buonavoglia C. In vitro virucidal activity of sodium hypochlorite against canine parvovirus type 2. Epidemiol Infect. 2018;146(15):2010–2013. doi:10.1017/S0950268818002431
   Web of Science ®Google Scholar
• Eterpi M, McDonnell G, Thomas V. Disinfection efficacy against parvoviruses compared with reference viruses. J Hosp Infect. 2009;73(1):64–70. doi:10.1016/j.jhin.2009.05.016
   Web of Science ®Google Scholar
• Sungkate S, Phongsamart W, Rungmaitree S, et al. Human parvovirus B19 nosocomial outbreak in healthcare personnel in a paediatric ward at a national tertiary referral centre in Thailand. J Hosp Infect. 2017;96(2):163–167. doi:10.1016/j.jhin.2017.03.014
   Web of Science ®Google Scholar
• Naides S. Infection control measures for human parvovirus B19 in the hospital setting. Infect Control Hosp Epidemiol. 1989;10(7):326–329. doi:10.2307/30146476
   Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Guidelines for environmental infection control in health-care facilities: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC). MMWR. 2003;52(RR–10):1–48.
   PubMedGoogle Scholar
• World Health Organization. Guidelines on hand hygiene in health care. Available from: https://www.who.int/infection-prevention/publications/hand-hygiene-2009/en/. Accessed September 11, 2020.
   Google Scholar
• Alves ADR, Langella BB, Barbosa JR, et al. High prevalence of parvovirus B19 infection in patients with chronic kidney disease under hemodialysis: a multicenter study. Int J Infect Dis. 2020;100:350–356. doi:10.1016/j.ijid.2020.09.010
   Web of Science ®Google Scholar
• Sharif A, Aghakhani A, Velayati AA, et al. Frequency and genotype of human parvovirus B19 among Iranian hemodialysis and peritoneal dialysis patients. Intervirology. 2016;59(3):179–185. doi:10.1159/000455124
   Web of Science ®Google Scholar